Press Releases

The May 2013 issue of Pharmacy Practice News (Volume 40) features an article sponsored by Intelligent Hospital Systems, and authored by Steve Frandzel with the title of “A Tale of Two IV Robots”, comparing both IV Robots’ costs, speed, size, features, return on investment, and customer satisfaction and experience.

Health Robotics’ i.v.STATION Robot continued on its undeterred path to collect endorsements and customer testimonials from pharmacists all over the world, documenting its unprecedented cost savings and patient safety benefits.

Health Robotics today announced the appointment of Gordon Meyer to its Board of Directors. Mr. Meyer has more than 30 years’experience in the health care industry with Sandoz Canada (Novartis), C.R. Bard, Sabex, and Baxter Canada, amongst others. During the last sixteen years at Sabex and Sandoz-Novartis he led a team that is the Canadian leader in hospital small volume parenteral injectables.

Health Robotics reported 28 new contracts in 1Q2013, including 12 new Robots [versus 6 Robots in 1Q2012; 8 for Oncology and 4 for non-hazardous IVs] and 16 new i.v.SOFT workflow software agreements [versus 11 i.v.SOFT contracts in 1Q2012]. After a dominant record overseas with almost 300 global installations outside the USA since 2007, http://www.health-robotics.com/en/installations/, Health Robotics is now also the clear leader in the United States’ Sterile Compounding Automation sector, with 30 Robots and 50 i.v.SOFT workflow installations, only two years after directly entering the North American market.

Health Robotics today announced that in response to competitive trends and overwhelming customer demand, it recently added support for LifeCare, while withdrawing sales support for all Fresenius Kabi’s IV consumables for all of its Robots. Health Robotics maintained its current support for IV Bags from Baxter (Aviva, Viaflo, Viaflex, INTRAVIATM), Hospira (VisIVTM), B.Braun (PAB® and Excel®), Grifols (Fleboflex®, Flebobag®), Otsuka, Impromediform, and Terumo.

Health Robotics today announced the already scheduled Pharmacy Symposium demonstrations [including private demos] of its world-leading Robots and IV Workflow solutions at the Amerinet 2013 Member Conference to be held May 19-22 in Orlando [FL]; the American Society of Health-System Pharmacists 2013 Summer Meeting to be organized June 1-5 in Minneapolis [MN]; and the Premier 2013 Breakthroughs Conference to be held June 11-14 in San Antonio [TX].

Health Robotics today announced the appointment of Steve Thomas to its Board of Directors, effective immediately. Mr. Thomas spent 15 years in the Computer Industry and four years in Information Services before becoming President of Pyxis Corporation in 1997 and Group President of Cardinal Health in 1999. In 2003 he acquired Valueselling Associates, a global sales training company. Then, in 2007 he became Chairman and CEO of For Health Technologies Inc., which under his leadership pioneered efforts in the Sterile Compounding Automation sector before being acquired by Baxa Corporation and later by Baxter International.

Amerinet Choice®, the preferred portfolio subsidiary of Amerinet, announced a new five-year exclusive agreement with Health Robotics for its world-leading Sterile Compounding Automation solutions i.v.STATION, i.v.STATION ONCO, and i.v.SOFT Workflow Management solutions.

For FY2012 Health Robotics today reported 39 new Robot sales [22 for Oncology, and 17 for non-hazardous IVs] plus 67 i.v.SOFT workflow software contracts, making 2012 yet another record year. For 4Q2012, the company reported 27 new contracts, including 11 I.V. Robots (5 for Oncology Therapy, and 6 for non-hazardous IVs) and 16 i.v.SOFT workflow software agreements, continuing its 4-year supremacy of the world’s Sterile Compounding Automation market. Now reaching over 350 total installations in the world [including over 90% of Oncology IV Robots global market share, and over 80% of total IV Robots global market share], Health Robotics continued to benefit in 2012 from its transition to a direct sales and service approach, now accounting for the majority of its gross revenues and profits.

Health Robotics reported today its first positive results originating from its 2012 change in distribution channels within the Gulf Cooperation Council (GCC) area, and the exclusive appointment of PharmaTech as the replacement of AHCSC. Health Robotics is pleased to extend its unique technology to the first GCC hospital to utilize i.v.STATION (or any other IV robotic technology) for pediatric patients.

Health Robotics reported today that it had signed in November and December of 2012 two long-term contract extensions of its exclusive partnership with Tosho Inc., including a substantial expansion of Tosho’s control over the robotic software and hardware components of Health Robotics’ developed medical devices, and the technology transfer of Sterile Compounding Robot manufacturing to Japan.

Health Robotics reported today that Mercy Medical Center in Cedar Rapids, Iowa issued today a press release to celebrate the launch of the first i.v.STATION ONCO in North America, and uploaded a video testimonial from Desmond Waters, Director of Pharmacy to: http://www.youtube.com/watch?v=r2GGBUHe32Q

Health Robotics reported today that it conducted a retrospective review of records for all “live” patient doses at its global Oncology Robot customers as of December 4, 2012, right after Intelligent Hospital Systems announced that their RIVA medical device had produced that same day its “first-ever chemotherapy patient dose”.

Health Robotics reported today that while it acknowledges the fact that 100% of i.v.STATION customers rate the product as a “buy it again” on the December 2012 KLAS IV Automation Report with a 80% overall satisfaction score, the company is making available its own comments on this undependable and defective KLAS report, particularly given KLAS’ biased methodology and trivial sample size (0.3% of the USA market) at: http://www.health-robotics.com/en/compare-products/klas/

Health Robotics reported today that Intelligent Hospital Systems/RIVA twice had to withdraw from its own website their prior false statements about Palomar Medical Center and Cottage Health System supposedly “de-installing and rejecting i.v.STATION”, directly as a result to Palomar and Cottage rebukes of IHS’ claims.

Health Robotics today announced that, effective January 1, 2013, it will fully comply with The Patient Protection and Affordable Care Act (ACA), including maximum health insurance benefits for its USA-based employees. Health Robotics is hopeful that its USA-based customers understand the need for small companies such as Health Robotics to transfer these additional operating costs and ACA’s mandatory excise [sales] taxes on FDA-regulated medical devices equally to both its USA not-for-profit [tax-exempt customers] and for-profit customers, effective March 1, 2013.

Health Robotics today announced that the University of Tennessee Medical Center in Knoxville [UTMC] has joined the growing number of American hospitals replacing their reliance on sterile compounding outsourcing with i.v.STATION. UTMC, a member of the Premier healthcare alliance, serves as a tertiary referral center for Eastern Tennessee, Southeast Kentucky and Western North Carolina. UTMC was the region's first Certified Primary Stroke Center and East Tennessee's first dedicated Heart Hospital, serving as the area’s only Level I Trauma Center.

Health Robotics today reported that in the wake of i.v.STATION’s multiple wins against RIVA, and in the middle of several ongoing competitive bids, Intelligent Hospital Systems desperately issued a press release this week in order to curtail additional losses to Health Robotics by spreading outright lies about i.v.STATION.

Health Robotics today reported a new i.v.STATION “Go Live” in record time at Wyoming Medical Center in Casper, Wyoming. This quick implementation highlights the benefits that Health-System Pharmacies can immediately garner from Health Robotics’ streamlined implementation processes, especially in light of the recent drug shortages and closures of NECC and Ameridose. Health Robotics’ customers continue leading the market towards insourcing of Sterile Compounding Automation, while taking advantage of the cost and patient safety benefits.

Health Robotics today disclosed its ASHP Mid-Year plans to emphasize its superior solutions for Health-Systems to deal with the recent industry problems due to outsourced sterile compounding company closures, shortages and safety risks, together with its unparalleled advances in Oncology Sterile Compounding at the American Society of Health System Pharmacists (ASHP) Midyear Meeting & Exhibition, to be held in Las Vegas on 2-5 December 2012 (Booth 853).

Health Robotics reported 16 new contracts in 3Q2012 including 8 I.V. Robots (3 for Oncology and 5 for non-hazardous IVs) and 8 i.v.SOFT agreements, continuing its 3-year supremacy of the global Sterile Compounding Automation market. On a year-to-date basis, YTD 2012 contracts reached an all-time record of 79 new installations over the last 9-month period, a 46% increase over 2011’s 54 new sales on a year-to-date basis. Health Robotics continues to benefit from its decision to transition into a higher-margin direct-sales approach, now accounting for 75%+ of Health Robotics’ revenues, compared to prior years’ dependency on distributors.

Health Robotics today announced the general availability of embedded Radio-frequency identification (RFID) for its world-leading Sterile Compounding Automation solutions i.v.STATION, i.v.SOFT, and i.v.STATION ONCO. These RFID upgrades will be showcased at the upcoming ASHP Midyear Meeting & Exhibition (American Society of Health-System Pharmacists) on December 2-6 in Las Vegas, Nevada at Booth # 853. At the same time, Health Robotics announced that it entered the Blood/Plasma Automation Industry by leveraging its unique technology benefits across the Pharmaceutical and Blood/Plasma industry sectors.

Health Robotics today announced that another member of the Premier healthcare alliance, Candler Hospital in Savannah, Georgia, is also benefiting from quality improvements and cost savings gleaned from its recent installation and “Go-Live” of the i.v.STATION Robot. Founded in 1804, not-for-profit Candler Hospital [a member of the St. Joseph’s/Candler Health System] is Georgia’s first hospital and second-longest continuously operating hospital in the United States of America.

Health Robotics today announced that Premier Healthcare Alliance’s member St. Joseph's Hospital in Savannah, Georgia is already saving at least $233,000 during FY2013 through its recent installation and “Go-Live” of the i.v.STATION Robot.

Health Robotics today announced that i.v.STATION and Mangiagalli’s Clinic won a national grant from the Vodafone Foundation, as selected by Vodafone customers’ votes from a group of potential projects, all of which were focused on children’s welfare. This grant provided funding for the i.v.STATION Robot at Mangiagalli, where 6,500 children are born every year, many of them requiring intensive care and complex medication dilutions (including multi-ingredient and double dilutions).

Health Robotics today reported 32 new contracts in 2Q2012, continuing its threeyear dominance of the global Sterile Compounding Automation market. On a yearto-date basis, 2012 new contracts reached an all-time record of 63 new contracted installations over the last 6-month period, a three-fold increase in sales bookings year-over-year. Health Robotics continued to consistently demonstrate that it is the only real choice in the Sterile Compounding Automation market, even beating its major competitor (Intelligent Hospital Systems-RIVA) in its own Canadian market.

Health Robotics today announced that offsite Batch Sterile Compounding Centers are quickly becoming a trend in USA’s hospital pharmacies’ attempt to lower the IVs price premiums they are currently incurring with companies such as Pharmedium and Ameridose for custom IV manufacturing, and Baxter, Hospira and B.Braun for Pre-Mix/Frozen solutions.

Health Robotics today announced that both Regina General Hospital and Pasqua Hospital from Regina Qu'Appelle Health Region (Saskatchewan) purchased 2 Health Robotics’ i.v.STATION Robots through Health Robotics’ exclusive partner Sandoz Canada, after Regina Qu'Appelle Health Region’s extensive due diligence, site visits, and 1Q2012 direct comparisons between Canadian-based Intelligent Hospital Systems’ RIVA and
i.v.STATION.

Health Robotics today announced FY2011 audited financial results, once again delivering record levels of revenues, gross margins, EBITDA, and profits, while concurrently weathering the economic world crisis, unfavorable Euro/Dollar exchange rates, and successfully defeating hostile takeover attempts and groundless lawsuits.

Health Robotics today announced a new marketing and service channel for its world-leading i.v.STATION ONCO, i.v.SOFT, and i.v.STATION products with Kingdom of Saudi Arabia-based market leader Hospital Automation Technology (HAT). Health Robotics continues to spearhead the global healthcare industry and persisting on its worldwide quest to provide safe and cost-effective Intravenous Admixture Compounding Automation all over the world.

Health Robotics today announced a new outstanding Award for its world-leading i.v.STATION Robot at Germany’s Hannover Messe, the world’s largest and most prominent technology trade fair. This new Award follows the 5th Annual Club Meccatronica Prize also won in 2011 by Health Robotics.

Health Robotics today announced a new marketing and service channel for its world-leading i.v.STATION ONCO, i.v.SOFT, and i.v.STATION products with United Arab Emirates-based PharmaTech. Health Robotics continues to spearhead the global healthcare industry and persisting on its worldwide quest to provide safe and cost-effective Intravenous Admixture Compounding Automation to hospitals all over the world.

Health Robotics today announced a new indirect sales and service channel for its world leading i.v.STATION ONCO, i.v.STATION, and i.v.SOFT products with Korean-based market leader Dongbang Healthdyne. Health Robotics continues to lead the global healthcare industry and persisting on its worldwide quest to pervasively provide safe and cost-effective Intravenous Admixture Compounding Automation to hospitals all over the world.

Health Robotics today announced its most recent competitive win through a public tender purchasing process at prestigious National Cancer Institute of Milan, where it defeated its former development partner Loccioni by a margin of 52 to 26 points. http://www.health-robotics.com/smartedit/downloads/en/avviso_aggiudicazione_farmacia.pdf

Health Robotics reported 31 new first quarter contracts in 1Q2012, traditionally the weakest on the calendar, with a three-fold increase in sales bookings year-over-year. Health Robotics continued to benefit from its prior decisions to terminate specific contracts with some under-performing distributors, and from switching channel strategies to directly manage customer operations in certain key countries.

Health Robotics today announced that it received additional recognition (this time in the USA) for its global customer accomplishments by being named to the Robotics’ Business Review Top 50 list.

Health Robotics announced that it has been recently awarded by Premier Healthcare Alliance a 3-year sole-source contract for its world-leading IV Robots, following Premier’s industry-wide market search in late 2011. Under this agreement, Premier will exclusively license Intravenous Medication Robots from Health Robotics.

Health Robotics today released its upcoming 2012 schedule for USA’s 56-city product education road tour, showcasing on-site demonstrations of its world-leading IV Automation solutions, directly in response to the extraordinary demand generated by its 2nd Generation robots and workflow tools post-ASHP Midyear.

Health Robotics logged another record trimester in 4Q2011, continuing to benefit from its year-old decisions to terminate its contracts with some under-performing distributors, switching channel strategies to directly manage customer operations in certain key countries, and persevering with its crucial approach to replace McKesson in North America.

After successfully switching marketing channel strategies from certain non-performing indirect distribution channels in several countries to Health Robotics’ direct management in 1Q2011, the company today announced the extension of the same control over local operations in Denmark, in partnership with local Oncology leader Novamed.

In Oncology Robotics news, Health Robotics today announced that it plans to exhibit far-reaching evidence of the underlying principles behind its Oncology Robotics’ world market supremacy at the American Society of Health System Pharmacists (ASHP) 46th Midyear Clinical Meeting & Exhibition, to be held at New Orleans, Louisiana on 4-8 December 2011 (Booth 619). Additionally, it will also introduce at ASHP a revolutionary, patent-pending, and fully automated Mechatronics solution [auxiliary mini-robot] for Monoclonal Antibodies (mAbs) and other sterile compounding auxiliary tasks, capable of reducing drug vials’ waste and patients’ negative side effects associated with human errors in delicate and complex powder/gels reconstitutions. With the aid of the auxiliary mini-robot, i.v.STATION’s and i.v.STATION ONCO’s further extend their current substantial speed advantages over their competitors by means of dual and parallel-robotic-arm-processing working in tandem and synergy.

Health Robotics announced that  prominent 850-bed medical center St-Antonius Hospital [Utrecht and Nieuwegein, The Netherlands] recently purchased 1 i.v.STATION Robot and agreed to provide Health Robotics with assistance in the protocol development for the complex and sterile compounding of Monoclonal Antibody (mAbs) therapy for i.v.STATION and i.v.STATION ONCO. Health Robotics will introduce the below described mAbs and other Oncology-focused upgrades to its world-leading robots at the American Society of Health System Pharmacists (ASHP) 46th Midyear Clinical Meeting & Exhibition, to be held at New Orleans (USA) on 4-8 December 2011 (Booth 619).

Health Robotics announced that CytoCare and Japan-based Tosho Inc. recently won a public tender purchasing process, sponsored by the Oxaliplatin Fund, at prestigious Nagoya City University Hospital’s Cancer Center http://www.med.nagoya-cu.ac.jp/w3med/en/index.html

Health Robotics today announced the successful implementation of i.v.STATION at Children’s Hospital Los Angeles, with the opening of its new and state-of-the-art hospital facility, the Marion and John E. Anderson Pavilion. Children’s Hospital Los Angeles is now the 6th i.v.STATION Robot operating in the United States of America, after Long Beach Memorial Hospital, Miller Children’s Hospital, Brigham & Women’s Hospital (2 Robots), and Allegiance Health.

Health Robotics today announced that Japan-based Tosho Inc. acquired an undisclosed minority stake of Health Robotics’ stock from some of its original founders, enabling it to successfully repel hostile takeover attempts by undisclosed American-based third parties, and to retain its independence.

Health Robotics today revealed some of its financial and clinical outcomes at Allegiance Health (Jackson, MI), directly resulting from its previously announced 2Q2011 marketing channel reorganization and the expansion of American installation and support services with its partner Health Robotics Canada.

Health Robotics today announced that it plans to unveil its revolutionary 2nd generation oncology robot i.v.STATION ONCO at the American Society of Health System Pharmacists (ASHP) 46th Midyear Clinical Meeting & Exhibition, to be held at New Orleans, Louisiana on December 4-8 2011. Additionally, Health Robotics revealed that its first i.v.STATION ONCO installation in America is scheduled to take place at Mercy Medical Center [Cedar Rapids, Iowa] in 1Q2012.

From a customer perspective, Health Robotics recorded its best-ever global trimester in 3Q2011, notably beginning to harvest benefits from its 1Q2011 decision to enter direct marketing operations in some countries, and persevering with its expense-intensive but essential strategy to replace McKesson in North America, which rapidly yielded 10 USA-based robots now in productive use.

Grifols and Health Robotics jointly announced today the expansion of their I.V. Room of the Future partnership to include the unmatched benefits of integration between Genesis Inventory Management System (distributed by Grifols) and Health Robotics’ i.v.STATION, i.v.STATION ONCO, and i.v.SOFT.

Health Robotics today announced that it recently won the 5th Annual Edition of the prestigious Club Meccatronica Award. Mechatronics is an interdisciplinary area of engineering that combines mechanical and electrical engineering and computer science. Examples of mechatronic systems are robots, digitally controlled machines, self-adaptive tools, automated guided vehicles, etc., all integrated with a prominent amount of system knowledge and embedded software. The award’s presentation is scheduled for tomorrow at the Reggio Emilia’s Valli Theater, by Ferrari’s CEO Luca Cordero di Montezemolo, and during the international seminar “Mechatronics 360°: How Mechatronics Technology Will Change Our Everyday Lives”.

Health Robotics today announced the immediate availability in the United States of an affordable rental program for Health Robotics’ undisputed world-leading I.V. Automation solutions i.v.STATION, i.v.SOFT Assist., and i.v.STATION ONCO. Initially launched in 2011 at the monthly rental fees of $5,500, $450, and $7,500 respectively, it persists with the post-McKesson replacement strategy and the expansion of Health Robotics Canada Inc. (HRCI) installation and support services.

Health Robotics today announced 1H2011 financial results [enclosed], delivering record levels of revenues, gross margins and net earnings for a six-month period. Gross Revenues reached $9.4 million (€6.5M) and Gross Margins were $7.3 million (€5M), respectively 42% and 72% increases over-year-ago period; both increases were directly linked to the significantly improved performance resulting from Health Robotics’ greater dependence on its own European and American based staff, replacing its prior, non-functioning indirect distribution and service channels.

Health Robotics S.r.l. today revealed that it had won a swift dismissal of McKesson’s previously announced lawsuit against the company http://www.mckesson.com/en_us/McKesson.com/About%2BUs/Newsroom/Press%2BReleases%2BArchives/2011/McKesson%2Bto%2BSeek%2BDiscontinuation%2Bof%2BStrategic%2BAgreement.html in a decision announced this week by U.S. Magistrate Judge Joseph C. Spero for the Northern District of California (Case Number C-11-00728 JCS), without the case even needing discovery, hearings, and/or case management phases.

Health Robotics announced that it launched its post-McKesson era with record-breaking American results in 2Q2011, including 4 new robot installs completed, 18 new installations under contract, and 4 new enterprise agreements with Sandoz Canada, Grifols, Americorp Financial, and Donawa Consulting that continued the expense-intensive process to replace McKesson Automation, while substantially expanding the service scope of Health Robotics Canada Inc. (HRCI).

Health Robotics today announced an additional key step in its previously broadcasted program to replace McKesson Automation http://www.health-robotics.com/smartedit/downloads/en/mck.pdf with the extension of its already successful European partnership with Grifols to comprise the companies’ joint marketing in the United States of America. Under the expanded agreement, Grifols’ operating subsidiary in Los Angeles will co-market Health Robotics’ i.v.STATION, i.v.SOFT, and i.v.STATION ONCO world-leading solutions to Health-System Pharmacies in the USA.

On the heels of its 5th Anniversary, Health Robotics announced that it had reached unprecedented Health-System Pharmacy industry acceptance milestones in its worldwide quest to pervasively provide safe and cost-effective Sterile Compounding Automation solutions to hospitals all over the world.

Health Robotics today announced the immediate general availability of preferred rental program options for the company’s world-leading solutions i.v.STATION, i.v.SOFT, CytoCare, and i.v.STATION ONCO, backed by Americorp Financial.

Health Robotics today announced that coinciding with the 5th anniversary of the company’s founding, it is currently conducting its Annual Training and Award Ceremonies for its worldwide channel line-up of service partners at the company’s brand new, Trieste-based, manufacturing and regulatory office locations.

Health Robotics today announced FY2010 audited results, delivering once again record levels of revenues and gross margins. Revenues in FY2010 were €10.7 million ($15M), a 21% increase year-over-year as Health Robotics continued to dominate IV Automation by winning 100% of all IV Robots’ globally announced purchase decisions in 2010. Gross Margins in FY2010 were €6.9 million ($10M), a 20% increase year-over-year related to the greater number of units installed.

Health Robotics today announced a new exclusive distribution agreement for its world-leading i.v.STATION ONCO, i.v.SOFT, and i.v.STATION products with Dominican Republic-based leader Macrotech Farmaceutica. This new exclusive partnership represents Health Robotics’ entry into its 20th new country over the past 2 years, persisting on its worldwide quest to pervasively provide safe and cost-effective Intravenous Admixture Compounding Automation to hospitals all over the world.

Health Robotics today announced the company’s 2011 Annual Scientific Advisory Board (SAC) Meeting, jointly hosted this week by Campus BioMedico University Hospital facilities in Rome and Health Robotics’ Research & Development Center in Trieste, Friuli-Venezia Giulia Region, Italy.

Health Robotics today announced last week’s execution of an exclusive distribution agreement for its CytoCare Cancer Therapy Robot with Costa Rica-based Pharmacy Compounding leader Nutricare S.A. This represents Health Robotics’ entry into its 19th new country over the past 20 months and first within Latin America, persisting on its worldwide quest to pervasively provide safe and cost-effective Intravenous Admixture Compounding Automation to hospitals all over the world.

Health Robotics reported overwhelming success at the European Association of Hospital Pharmacists (EAHP) 2011 Annual Symposium in Vienna, where its Executive VP Gaspar DeViedma was invited to publicly share the clinical, financial, and throughput/efficiency results at 45 of Health Robotics’ global installations for two of its industry-leading robots: i.v.STATION and CytoCare.

Health Robotics today announced its official response to McKesson’s wrongful and public allegations with regards to: 1) Health Robotics’ intellectual property and licensing rights, and 2) Health Robotics’ development partnerships with 3 Italy-based companies for CytoCare, i.v.STATION, and i.v.SOFT.

Download Press Release

Health Robotics today announced that it recently signed an exclusive distribution agreement for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies with Israel-based medical technology leader Gamida MedEquip Ltd. This partnership represents Health Robotics’ market entry into its 17th new country over the past 20 months, persisting on its worldwide quest to pervasively provide safe and cost-effective Intravenous (IV) Admixture Compounding Automation to hospitals all over the world.

Health Robotics today announced the completion of its initial research, development, and factory-testing activities for its next-generation Cancer Therapy Robot, i.v.STATION ONCO, and its unveiling at the European Association of Hospital Pharmacists (EAHP) in Vienna on 1 April 2011, including its new overpowering features: four times faster, five times smaller, and three times less expensive than some of the other Sterile Compounding Robotic devices in the market.

Health Robotics today announced that earlier last week, it served proper notice to McKesson of the immediate termination for cause of their exclusive CytoCare distribution and services contract in North America, as well as the termination for cause of their non-exclusive distribution agreement for i.v.STATION and i.v.SOFT within a subset of McKesson Automation’s customers.

Health Robotics today announced that it recently decided to re-start sales and service operations in Italy, after a three-year absence in connection with a prior agreement with Gruppo Loccioni. With over 60 hospital customers under contract carried forward from the company’s 2006-2007 presence in the Italian market, Health Robotics is on the brink to replicate its worldwide success within its home country of Italy. The company’s All-Digital solutions, including Oncology Care, will continued to be showcased at its pre-2008 installations: Campus Biomedico University Hospital, La Maddalena Cancer Center, Ospedale di Treviso, Gruppo Auxologico in Milan, and Bolzano General Hospital.

Health Robotics today announced the official opening and live operation of the largest Sterile Compounding Center for Oncology patients in the world. Akdeniz University Hospital in Antalya (Turkey) compounds 90% of its 80.000 annual chemotherapy intravenous doses with 4 CytoCare robots and related Health Robotics’ technology, or an average of 325 patient doses per 6-hour work cycle. The Oncology Pharmacy at the 600-bed hospital is jointly operated by the hospital’s staff and by Rivosem, Health Robotics’ exclusive partner in Turkey and Central Asia.

Health Robotics today announced its first 2011 contract for the installation of 2 i.v.STATION robots at Children’s Hospital of Los Angeles, marking the third California hospital, after Cottage Health System and Memorial Care, to purchase 2 i.v.STATIONs each. The installation of the 2 i.v.STATIONs is scheduled to occur during 1Q2011 initially focusing on antibiotics and controlled substances, and in conjunction with Health Robotics’ i.v.SOFT Assist Workflow Engine for Chemotherapy. Finally, this new agreement also represents the third i.v.STATION for Pediatrics sold in the United States of America, after Miller Children’s Hospital in Long Beach.

Health Robotics today announced record-breaking annual results in North America, as reported by our partners McKesson and Health Robotics Canada Inc. (HRCI), including new 4Q2010 North American contracts for 2 CytoCare, 2 i.v.STATION, and 1 I.V. Room of the Future projects, bringing Health Robotics’ total to 31 new American contracted installations in 2010, compared to 1 new contract announced by all direct competitors combined within the same 12-month period, and also in contrast to zero contracts delivered by our prior American distribution channels during 2009, before the sales and service channel upgrades to McKesson and HRCI took place.

Health Robotics today announced that it recently signed an exclusive cooperation agreement for Grifols to significantly contribute to its I.V. Room of the Future Initiative with its Misterium state-of-the-art Clean Room products and I.V. Therapy and Clinical Nutrition scientific knowledge and experience. The agreement also includes the appointment of Grifols’ scientific expert Dr. Oriol Prat as an additional member of Health Robotics’ Scientific Advisory Board, where he will join representatives of The Cleveland Clinic Foundation, Ochsner Clinic, Sutter Health, USC University Hospital, and The University of Chicago Medical Center.

Health Robotics today announced that it recently signed an exclusive distribution agreement in Norway for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies with local Pharmacy Technology leader Beckman Automation AS. This partnership represents Health Robotics’ market entry into its 12th new country in 2010, persisting on its worldwide quest to pervasively provide safe and cost-effective Intravenous (IV) Admixture Compounding Automation to hospitals all over the world.

Health Robotics today announced that it recently signed exclusive distribution agreements for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies in seven new European countries with regional industry leaders Newico and Apta Medica, rapidly continuing on its worldwide quest to pervasively provide safe and cost-effective Intravenous (IV) Admixture Compounding Automation to hospitals all over the world.

Health Robotics today announced that it recently signed five exclusive distribution agreements for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies in four Eastern European countries, rapidly continuing on its worldwide quest to pervasively provide safe and cost-effective Intravenous (IV) Admixture Compounding Automation.

Health Robotics released the results of the first 20 financial i.v.STATION studies conducted by selected North American channel partners at various Academic, Community, Pediatric, and Oncology hospitals in Alabama, California, Florida, Illinois, Louisiana, Massachusetts, Michigan, Ohio, Ontario, Pennsylvania, Quebec, and Texas. These studies compared the direct costs of i.v.STATION-produced sterile doses to compounded IVs manufactured by 6 Pharmacy Outsourcing and Pre-Mix/Frozen solutions companies. Health Robotics’ web-registered authorized users may access i.v.STATION’s ROI case studies and custom Microsoft Excel tools at http://www.health-robotics.com/en/solutions/i-v-station/ .

Health Robotics today announced that BioRobotics, on the heels of its unprecedented market success with its line of Oncology Surgery robots, has exclusively selected Health Robotics’ i.v.STATION Robot and i.v.SOFT Workflow Engine to complete its objective to become the gold standard for IV Admixtures Automation in the Republic of Korea, building on top of its CytoCare exclusive agreement nine months ago.

Health Robotics announced its second consecutive quarter’s record-breaking results, as reported by our sales channel partner Health Robotics Canada Inc. (HRCI) since Health Robotics S.r.l. upgraded its American distribution channels this year. HRCI’s impressive results included new North American contracts for 4 i.v.STATION, 4 i.v.SOFT, and 3 I.V. Room of the Future projects, bringing Health Robotics’ 2010 first semester total to 26 new American contracted installations, compared to 1 new contract announced by all of our direct competitors combined within the same 6-month period, and to zero contracts signed by our prior North American distribution channels during the entire 2009 year.

Health Robotics announced that it has reached final agreements to acquire all assets from Italy-based MEDarchiver S.r.l. and Biomedical Technology Consulting S.r.l., merging these companies’ employees and operations, re-entering direct sales activities in the Italian market, and conducting a re-organization of its Executive Management, expecting to close these acquisitions over the next few months.

Health Robotics today announced that it recently signed agreements to grant exclusive CytoCare distribution rights in Spain and Portugal to world-leading IV Therapy company Grifols S.A., and to install the first-ever Cancer Therapy Robot in Spain at Vall d’Hebron University Hospital in Barcelona in November 2010.

Health Robotics announced that its joint-venture Health Robotics Canada Inc. (HRCI), a leading Canadian Pharmaceutical Company, and a well-established Quebec-based Medical Device Technology company have all recently signed marketing agreements in order to expand into Canada the market presence of i.v.STATION and i.v.SOFT, revolutionary technologies that provide automated sterile compounding of intravenous medications and parenteral nutrition to hospitals.

Health Robotics today announced that its joint venture Health Robotics South East Asia Ltd. scored two strategic wins by reaching agreements on two separate government-sponsored projects to deliver CytoCare-made accurate and sterile oncology patient doses in Kuala Lumpur and Bangkok, respectively. Health Robotics’ CytoCare is the first-and-only robot in the world proven to automatically compound and dispense oncology intra-venous therapy treatments to patients.

Health Robotics today announced that on the heels of the recently announced Health Robotics-McKesson exclusive partnership [http://www.pr-inside.com/mckesson-expands-i-v-automation-portfolio-r1873650.htm] i.v.SOFT and i.v.STATION new product designs and Q&A sessions will be held at the McKesson booth [701] of the American Society of Health-System Pharmacists’ Summer Meeting (ASHP) in Tampa, Florida, June 6-8, 2010.

Health Robotics and B. Braun Melsungen AG today announced that in exchange for undisclosed consideration, Health Robotics has re-acquired from B. Braun the exclusive marketing, sales, installation, implementation, interface, manufacturing, and technical support European rights for CytoCare, a robot designed to manufacture chemotherapy and hazardous IV Admixtures, and which rights B. Braun had previously acquired from Health Robotics in 2007 and 2008. This amendment to the prior agreements includes the transition of all CytoCare customer contracts from B. Braun to direct Health Robotics' technical support starting on July 1st, 2010.

Health Robotics today announced i.v.STATION’s certification achieving compliance with a host of global security guidelines for controlled substances, including tamper-evident syringe caps, biometric identification, restricting nursing access only to ready-to-administer IVs, single-dose storage and retrieval, etc.

Health Robotics today announced the upcoming cooperation with the International Society of Oncology Pharmacy Practitioners (ISOPP), B|Braun Melsungen, and the General Faculty Hospital of Prague to host ISOPP delegates at its bi-annual congress to witness live demonstrations of CytoCare in an Oncology patient setting. CytoCare is the only robot in the world proven to compound hazardous sterile I.V. Admixtures. ISOPP 2010 delegates may reserve attendance to this invitation-only event (space limited) at http://www.isopp2010.com/en/health-robotics.

Health Robotics today announced the outstanding results reported by one of its American partners, Health Robotics Canada Inc. (HRCI) first trimester of operations since its inception in December 2009. These impressive results included new contracts in North America for seven i.v.STATION, six i.v.SOFT, one CytoCare, and one I.V. Room of the Future, quickly eclipsing in its first three months of existence all the other I.V. Automation companies that have been present in the field of North American I.V. Robotics for the past 22 years, including IHS/RIVA .

As part of its I.V. Room of the Future initiative to cooperate with other industry leaders, Health Robotics today announced the immediate availability of its revolutionary Virtual High-Availability Architecture (up to 99.99%), including state-of-the-art, virtualization compliant, cluster and fail-over, disaster recovery, and back-up solutions for its CytoCare and i.v.STATION robots [with future expansion to TPNstation when available], and its i.v.SOFT Workflow Engine for manual compounding, all of this at a fraction of the cost of competitors’ obsolete and uncertain robotic designs that lack back-up and redundancy features despite their much higher cost of ownership.

Health Robotics today announced the successful global launch of the Beta Installation kick-off for its 3 latest i.v.SOFT Workflow Engine software automation modules [Assist, Label+ and Profile] in Nice [France], the 2010 venue for the European Association of Hospital Pharmacists.

Health Robotics today announced FY2009 results, delivering once again record levels of revenues, profits and cash flow, overcoming a difficult global economic climate and the short-term consequences of its decision to terminate non-performing sales and service channels in North America and Asia-Pacific.

Health Robotics today announced the public evaluation of video speed tests between i.v.STATION and RIVA sterile compounding robots, based on each companies’ public video testimonials at their respective web sites of an identical powder reconstitution (80 ml) and size/dose of syringe (10cc). Founded on this side-by-side comparison and other publicly available information, it is now evident that i.v.STATION is 3.8 times faster than RIVA. When additionally factoring in RIVA’s fiveA times higher price, i.v.STATION is 20 times less expensive than RIVA on a per-dose basis.

Health Robotics, the undisputed worldwide leading supplier of life-critical I.V. Robots, today announced that it has been recently awarded by SGS (Societé General de Surveillance) the ISO certification (according to the UN EN ISO 9001:2008 norm), the globally accepted standard for companies to prove their ability to satisfy quality requirements and to enhance customer satisfaction in supplier-customer relationships.

Health Robotics today announced the successful completion of the transition from its prior sales and support channels in North America to McKesson and Health Robotics Canada Inc., with triple digit growth in sales and installations, renewal of North American customers’ commitment to Health Robotics’ world-leading and revolutionary products, and greatly improved customer satisfaction.

Health Robotics today announced its plans to unveil TPNstation’s development plans and product specifications for a new and revolutionary concept: “Totally Automated Parenteral Nutrition”, a new key component of its i.v. Room of the Future vision to be showcased at Las Vegas’ ASHP (Booth # 114).

Health Robotics today announced that it has formed a new Canadian joint venture with a group of selected investors. This recently formed Toronto-based company will operate under the name Health Robotics Canada, Inc. and will market, install, and support Health Robotics’ i.v. Room of the Future concept, which includes the revolutionary product offerings i.v.STATION™, i.v.SOFT™, and OMM™.

Health Robotics today announced the worldwide presentation and launch of its revolutionary vision for “The i.v. Room of the Future” at the American Society of Health-System Pharmacists’ Mid-Year Meeting December 6-10 in Las Vegas, along with an initial consortium of development partners that currently includes Biomedical Technology Consulting and MEDarchiver.

Health Robotics today announced that Innomed/BioRobotics, on the heels of its prior market success with Oncology Surgery robots, has exclusively selected Health Robotics’ CytoCare™ Robot to reach its objective to become the gold standard for Oncology Robotics IV Admixtures in the Republic of Korea and synergistically provide an end-to-end Cancer Robotics solution.

Health Robotics today announced the worldwide presentation and launch of its new i.v.SOFT Workflow Engine at the American Society of Health-System Pharmacists’ Mid-Year Meeting December 6-10 in Las Vegas.

Health Robotics today announced that Juan Jose Güemes, Health Secretary of State for Madrid’s Regional Government officially unveiled i.v.STATION at Gregorio Marañón University Hospital in Madrid last Monday.

Health Robotics today announced the manufacturing, shipment, and subsequent field installation of the first five i.v.STATION post-prototype robots in the United States of America and in Spain within the September to November timeframe this year; concurrently, Health Robotics also made the announcement of its i.v.STATION robot’s winning of the Area Science Park 3L 3T Innovation Award, which is given to the best technology product across all industries.

Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Grifols International S.A. for its revolutionary CytoCare Robot. The agreement enables Grifols to add CytoCare to its prior i.v.STATION™ contract with Health Robotics, and achieve its objective to safely, accurately and cost-effectively automate the preparation of Oncology I.V. Admixtures in Mexico, Chile, Brazil, Argentina, Uruguay, Paraguay, Bolivia, Peru, Venezuela, Colombia, Ecuador, Panama, Costa Rica, Belize, Nicaragua, El Salvador, Honduras, Guatemala, Surinam, French Guyana, and Guyana.

Health Robotics today announced that it has signed an exclusive five-year strategic agreement with China National Pharmaceutical Foreign Trade Corporation (SINOPHARM Foreign Trade), a wholly owned People’s Republic of China Government (PRC) company, for its revolutionary CytoCare™ and i.v.STATION™ Robots.

Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Device Technologies Australia Pty Ltd. for its revolutionary CytoCare™ Robot.

Health Robotics today reported that Dr M Group has selected the CytoCare™ and i.v.STATION™ Robots to be deployed across all of its I.V. Compounding Centers in Malaysia, Singapore, Indonesia, Vietnam, and India.

Tosho’s Satisfaction with Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I.V. Automation Strategic Partnership.

Health Robotics today announced that National Taiwan University Hospital (NTUH) has purchased and agreed to immediately install its flagship CytoCare Robot during 2009. Separately, it also announced that it has signed an exclusive 3-year distribution, licensing, and support contract with Pinnaclemed.

Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership

Gregorio Marañón Foundation Pioneers the Prevention of Pediatric Errors as the 1st European Installation of i.v.STATION™

McKesson Expands Pharmacy Automation Product Portfolio to Include I.V. Therapy - Strategic Partnership Announced with Health Robotics

Health Robotics Announces American Joint Venture with i.v.SOFT

Health Robotics Announces to Launch Germany’s Installtions of i.v.STATION™ at Charité-Universitätsmedizin Berlin

Health Robotics Announces to Expand and Diversify Global Channel Strategies with Joint-Ventures & Direct Operations

Health Robotics Announces i.v.STATION™ Contract with Grifols in Spain, Portugal, and South America

Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008

Health Robotics Announces the Early Release of the i.v.STATION™ Profile Option and DUPHAT Presentation

Health Robotics Announces European Launch of i.v.STATION™ and Global list of 2009 Installations

Health Robotics expands i.v.STATION™ Partnership with Can-Med in 10 countries within Central Asia

Health Robotics Announces Results of the European Union-sponsored SafeChemo Project

Health Robotics Announces Partnership in the People’s Republic of China with The Devon International Group

ICU Medical Inc. and Health Robotics announce compatibility of CytoCare™ Robot and CLAVE® Needle-Free Connector to enable safer hazardous drug handling

Health Robotics to Launch i.v.STATION™ Robot at ASHP and Kick-off 12 Global Beta Installations Next Week

Health Robotics announces $60M investment by Devon International Group and ITOCHU Inc. in the CytoCare™ and i.v.STATION™ Robots

Health Robotics announces strategic partnership in Japan for its CytoCare™ Robot with TOSHO Inc.

Health Robotics announces contract for its CytoCare™ and i.v.STATION™ Robots with Arabian Health Care Supply Corporation

Health Robotics announces immediate availability of IV Robot for newest hazardous drug class: Monoclonal Antibodies Therapy

Health Robotics announces a new exclusive partnership for its CytoCare™ Robot and a review of its customer adoption and sales operations worldwide over the last 12 months

Health Robotics announces its first large i.v.STATION™ contract to initially deliver fifty-six (56) robots to Turkey's hospital pharmacies over the next twenty-four months

Health Robotics announces IV Station (TM Pending) a centrally controlled, modular, distributed, flexible, redundant, patient-specific intra-venous (IV) Automation Robot for non-hazardous drug preparation, compounding, and dispensing in central pharmacy locations, satellite pharmacies, and even patient care workplaces